Leonteq Securities’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Leonteq Securities's IONS Position: Q3 2026 in Review
Leonteq Securities increased its Ionis Pharmaceuticals (IONS) stake by 1,397% in Q3 2026, buying an estimated $58K and bringing the position to 1,093 shares worth $48.8K. The position accounts for ﹤0.01% of the portfolio, ranked #781.
Leonteq Securities first reported a position in IONS in Q4 2020 and has held it in 21 quarters since. The position peaked at $190K in Q4 2021. 356 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Leonteq Securities held 1,093 shares of Ionis Pharmaceuticals worth $48.8K as of Q3 2026.
- Leonteq Securities bought 1,020 Ionis Pharmaceuticals shares in Q3 2026, an estimated $58K.
- Ionis Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #781 holding.
- Leonteq Securities first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
- Leonteq Securities's Ionis Pharmaceuticals position peaked at $190K in Q4 2021.
- 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.